Breaking News

PCI Pharma Services Receives Strategic Investment from Bain Capital, Kohlberg and Mubadala

Will support PCI's growth initiatives, including expanding its suite of services and geographic reach.

Author Image

By: Charlie Sternberg

Associate Editor

PCI Pharma Services, a global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company. Partners Group will also continue to support the Company with a minority investment. Financial terms of the private transaction were not disclosed. Headquartered in Philadelphia, PA, PCI provides drug...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters